BioMedTech August 19, 2019 Inclusion of the first patient in Abivax's Phase 2b (ABX464-103) clinical trial for the treatment of hemorrhagic rectocolitis The main evaluation criterion is the reduction of Mayo's score to 8 weeks.
BioMedTech August 1, 2019 Abivax treats first rheumatoid arthritis patient in Phase 2a clinical trial The clinical trial was approved in the following four European countries: France, Poland, Czech Republic and Hungary ...
